Answers are grounded in this paper and cite their sources.
Introduction Cells must adapt to extracellular matrix‐derived microenvironments during tissue repair, but the intracellular mechanisms governing this adaptation remain incompletely understood. Methods Urinary bladder matrix (UBM) was used as a model extracellular matrix scaffold to investigate cellular expansion and mitochondrial function. HT1080 cells, HaCaT keratinocytes and primary human vaginal fibroblasts were examined using pharmacological modulation, CRISPR‐Cas9‐mediated gene disruption, transcriptomic analysis and mitochondrial perturbation assays. Results UBM produced comparatively high CCK‐8 activity among the tested biomaterials but restricted cellular expansion relative to standard culture conditions. This phenotype was accompanied by lower DCFH‐DA and MitoSOX fluorescence, lower TMRE and MitoTracker Green fluorescence, and reduced ATP content. NRF2 activation with bardoxolone or omaveloxolone increased cellular expansion, whereas NRF2 inhibition or NRF2 deficiency weakened this response. TXNRD1 was identified as an NRF2‐responsive candidate through transcriptomic analysis and protein validation. Auranofin attenuated growth‐associated and mitochondrial responses to NRF2 agonists, while TXNRD1 deficiency weakened the bardoxolone-associated CCK‐8 increase. EdU incorporation independently confirmed that FCCP, oligomycin and rotenone reduced the bardoxolone‐associated increase in DNA synthesis. In vivo , systemic NRF2 agonism improved wound repair in the presence of UBM, whereas auranofin co‐treatment reduced this benefit. Discussion These findings identify NRF2–TXNRD1‐associated metabolic adaptation as a potentially modifiable component of cellular responses to UBM and support further investigation of this pathway in scaffold-assisted tissue repair.
No takes yet. Share an insight, caveat, or question.
Tong et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: